Atlas Trials

Melatonin and DNA Damage Study

Clinical trial NCT03945955 · COMPLETED

Trial details

NCT number
NCT03945955
Sponsor
University of British Columbia
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Sleep QualityDNA Damage Repair DeficiencyOxidative Stress
Start date
2022-06-01
Primary completion
2023-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.